Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth

Molecular Biology of the Cell

Volumn 18, Issue 3, 2007, Pages 755-767

  Wu, Kongming ^a   Liu, Manran ^a   Li, Anping ^a   Donninger, Howard ^b   Rao, Mahadev ^c   Jiao, Xuanmao ^a   Lisanti, Michael P ^a   Cvekl, Ales ^d   Birrer, Michael ^b   Pestell, Richard G ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; CYCLIN A; DNA BINDING PROTEIN; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; PROTEIN DACH1; PROTEIN SUBUNIT; STATHMIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENZYME REGULATION; ENZYME REPRESSION; ENZYME SUBUNIT; GENE CONTROL; GENE DELETION; GENE REPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; REGULATORY MECHANISM; TRANSACTIVATION; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS;

ANIMALS; BINDING SITES; CELL COMMUNICATION; CELL LINEAGE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONSERVED SEQUENCE; CONTACT INHIBITION; DNA; EYE PROTEINS; GENE EXPRESSION; HUMANS; MICE; NIH 3T3 CELLS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; SERUM RESPONSE ELEMENT; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TWO-HYBRID SYSTEM TECHNIQUES;

METAZOA;

EID: 33947189599     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E06-09-0793     Document Type: Article

References (70)

1. Alani, R., Brown, P., Binetruy, B., Dosaka, H., Rosenberg, R. K., Angel, P., Karin, M., and Birrer, M. J. (1991). The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells. Mol. Cell Biol. 11, 6286-6295.
2. ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270, 23589-23597.
3. Albanese, C. et al. (2003). IKKalpha Regulates Mitogenic Signaling through Transcriptional Induction of Cyclin D1 via Tcf. Mol. Biol. Cell 14, 585-599.
4. Angel, P., Hattori, K., Smeal, T., and Karin, M. (1988). The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55, 875-885.
5. Angel, P., and Karin, M. (1991). The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072, 129-157.
6. Baichwal, V. R., Park, A., and Tjian, R. (1991). v-Src and EJ Ras alleviate repression of c-Jun by a cell-specific inhibitor. Nature 352, 165-168.
7. Baichwal, V. R., and Tjian, R. (1990). Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain delta: differences between v- and c-Jun. Cell 63, 815-825.
8. Bannister, A. J., Cook, A., and Kouzarides, T. (1991). In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes. Oncogene 6, 1243-1250.
9. Behrens, A., Jochum, W., Sibilia, M., and Wagner, E. F. (2000). Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene 19, 2657-2663.
10. Binetruy, B., Smeal, T., and Karin, M. (1991). Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature 351, 122-127.
11. Bohmann, D., and Tjian, R. (1989). Biochemical analysis of transcriptional activation by Jun: differential activity of c- and v-Jun. Cell 59, 709-717.
12. Chen, R., Amouri, M., Zhang, Z., and Mardon, G. (1997). Dachshund and eyes absent proteins form a complex and function synergistically to induce ectopic eye development in Drosophila. Cell 91, 893-903.
13. Dai, T., Rubie, E., Franklin, C. C., Kraft, A., Gillespie, D. A., Avruch, J., Kyriakis, J. M., and Woodgett, J. R. (1995). Stress-activated protein kinases bind directly to the delta domain of c-Jun in resting cells: implications for repression of c-Jun function. Oncogene 10, 849-855.
14. Davis, R. J., Shen, W., Heanue, T. A., and Mardon, G. (1999). Mouse Dach, a homologue of Drosophila dachshund, is expressed in the developing retina, brain and limbs. Dev. Genes Evol. 209, 526-536.
15. Eferl, R., Ricci, R., Kenner, L., Zenz, R., David, J. P., Rath, M., and Wagner, E. F. (2003). Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112, 181-192.
16. Eferl, R., Sibilia, M., Hilberg, F., Fuchsbichler, A., Kufferath, I., Guertl, B., Zenz, R., Wagner, E. F., and Zatloukal, K. (1999). Functions of c-Jun in liver and heart development. J. Cell Biol. 145, 1049-1061.
17. Fu, M., Rao, M., Wu, K., Wang, C., Zhang, X., Hessien, M., Yeung, Y. G., Gioeli, D., Weber, M. J., and Pestell, R. G. (2004). The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. J. Biol. Chem. 279, 29436-29449.
18. Fu, M., Wang, C., Reutens, A. T., Wang, J., Angeletti, R. H., Siconolfi-Baez, L., Ogryzko, V., Avantaggiati, M. L., and Pestell, R. G. (2000). p300 and p300/ cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J. Biol. Chem. 275, 20853-20860.
19. Fu, M. et al. (2003). Acetylation of the androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol. Cell Biol. 23, 8563-8575.
20. Fu, M. et al. (2002). Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. Mol. Cell Biol. 22, 3373-3388.
21. Fuchs, S. Y., Dolan, L., Davis, R. J., and Ronai, Z. (1996). Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. Oncogene 13, 1531-1535.
22. Gao, M., Labuda, T., Xia, Y., Gallagher, E., Fang, D., Liu, Y. C., and Karin, M. (2004). Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 306, 271-275.
23. Hill, C. S., Wynne, J., and Treisman, R. (1995). The Rho family of Rho A, Rac 1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81, 1159-1170.
24. Hommura, F., Katabami, M., Leaner, V. D., Donninger, H., Sumter, T. F., Resar, L. M., and Birrer, M. J. (2004). HMG-I/Y is a c-Jun/activator protein-1 target gene and is necessary for c-Jun-induced anchorage-independent growth in Ratla cells. Mol. Cancer Res. 2, 305-314.
25. Ikeda, K., Watanabe, Y., Sno, H., Ohto, I., and Kawakami, K. (2002). Molecular interaction and synergistic activation of a promoter by Six, Eya, and Dach proteins mediated through CREB binding protein. Mol. Cell Biol. 22, 6759-6766.
26. Jochum, W., Passegue, E., and Wagner, E. F. (2001). AP-1 in mouse development and tumorigenesis. Oncogene 20, 2401-2412.
27. Johnson, R., Spiegelman, B., Hanahan, D., and Wisdom, R. (1996). Cellular transformation and malignancy induced by ras require c-jun. Mol. Cell Biol. 16, 4504-4511.
28. Kallunki, P., Jenkinson, S., Edelman, G. M., and Jones, F. S. (1995). Silencer elements modulate the expression of the gene for the neuron-glia cell adhesion molecule, Ng-CAM. J. Biol. Chem. 270, 21291-21298.
29. Kallunki, T., Deng, T., Hibi, M., and Karin, M. (1996). c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell 87, 929-939.
30. Karin, M., Liu, Z., and Zandi, E. (1997). AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240-246.
31. Katabami, M., Donninger, H., Hommura, F., Leaner, V. D., Kinoshita, I., Chick, J. F., and Birrer, M. J. (2005). Cyclin A is a c-Jun target gene and is necessary for c-Jun-induced anchorage-independent growth in Ratla cells. J. Biol. Chem. 280, 16728-16738.
32. Kawakami, K., Sato, S., Ozaki, H., and Ikeda, K. (2000). Six family genes-structure and function as transcription factors and their roles in development. Bioessays 22, 616-626.
33. Kayahara, M., Wang, X., and Tournier, C. (2005). Selective regulation of c-jun gene expression by mitogen-activated protein kinases via the 12-O-tetradecanoylphorbol-13-acetate-responsive element and myocyte enhancer factor 2 binding sites. Mol. Cell Biol. 25, 3784-3792.
34. Kennedy, N. J., Sluss, H. K., Jones, S. N., Bar-Sagi, D., Flavell, R. A., and Davis, R. J. (2003). Suppression of Ras-stimulated transformation by the JNK signal transduction pathway. Genes Dev. 17, 629-637.
35. Kinoshita, I., Leaner, V., Katabami, M., Manzano, R. G., Dent, P., Sabichi, A., and Birrer, M. J. (2003). Identification of cJun-responsive genes in Rat-1a cells using multiple techniques: increased expression of stathmin is necessary for c-Jun-mediated anchorage-independent growth. Oncogene 22, 2710-2722.
36. Kleemann, R. et al. (2000). Intracellular action of the cytokine MEF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408, 211-216.
37. Kovary, K., and Bravo, R. (1991). The Jun and Fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell Biol. 11, 4466-4472.
38. Kozmik, Z., Pfeffer, P., Kralova, J., Paces, J., Paces, V., Kalousova, A., and Cvekl, A. (1999). Molecular cloning and expression of the human and mouse homologues of the Drosophila dachshund gene. Dev. Genes Evol. 209, 537-545.
39. Lee, J.-S., Collins, K. M., Brown, A. L., Lee, C.-H., and Chung, J. H. (2000a). hCdsl-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404, 201-204.
40. Lee, R. J. et al. (2000b). Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway. Mol. Cell Biol. 20, 672-683.
41. Li, X. et al. (2003). Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature 426, 247-254.
42. Ljungdahl, S., Linder, S., Sollerbrant, K., Svensson, C., and Shoshan, M. C. (1997). Signal transduction in fibroblasts stably transformed by [Val12]Ras-the activities of extracellular-signal-regulated kinase and Jun N-terminal kinase are only moderately increased, and the activity of the delta-inhibitor of c-Jun is not alleviated. Eur. J. Biochem. 249, 648-656.
43. Maeda, S., and Karin, M. (2003). Oncogene at last-c-Jun promotes liver cancer in mice. Cancer Cell 3, 102-104.
44. Mayr, B., and Montminy, M. (2001). Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2, 599-609.
45. Miralles, F., Posern, G., Zaromytidou, A. I., and Treisman, R. (2003). Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113, 329-342.
46. Morton, S., Davis, R. J., McLaren, A., and Cohen, P. (2003). A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J. 22, 3876-3886.
47. Musti, A. M., Treier, M., and Bohmann, D. (1997). Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275, 400-402.
48. Nateri, A. S., Riera-Sans, L., Da Costa, C., and Behrens, A. (2004). The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling. Science 303, 1374-1378.
49. Piu, F., Aronheim, A., Katz, S., and Karin, M. (2001). AP-1 repressor protein JDP-2, inhibition of UV-mediated apoptosis through p53 down-regulation. Mol. Cell Biol. 21, 3012-3024.
50. Rapp, U. R., Troppmair, J., Beck, T., and Birrer, M. J. (1994). Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant. Oncogene 9, 3493-3498.
51. Ryseck, R.-P., Hirai, S. I., Yaniv, M., and Bravo, R. (1988). Transcriptional activation of c-jun during the Go/G1 transition in mouse fibroblasts. Nature 334, 535-537.
52. Sage, J., Miller, A. L., Perez-Mancera, P. A., Wysocki, J. M., and Jacks, T. (2003). Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424, 223-228.
53. Schreiber, M., Kolbus, A., Piu, F., Szabowski, A., Mohle-Steinlein, U., Tian, J., Karin, M., Angel, P., and Wagner, E. F. (1999). Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13, 607-619.
54. Schutte, J., Viallet, J., Nau, M., Segal, S., Federiko, J., and Minna, J. (1989). JunB inhibits and c-fos stimulates the transforming and transactivating activities of c-jun. Cell 59, 987-997.
55. Smeal, T., Binetruy, B., Mercola, D. A., Birrer, M., and Karin, M. (1991). Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354, 494-494.
56. Sotiropoulos, A., Gineitis, D., Copeland, J., and Treisman, R. (1999). Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98, 159-169.
57. Sprowles, A., and Wisdom, R. (2003). Oncogenic effect of delta deletion in v-Jun does not result from uncoupling Jun from JNK signaling. Oncogene 22, 498-506.
58. Todaro, G. J., and Green, H. (1963). Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17, 299-313.
59. Treier, M., Staszewski, L. M., and Bohmann, D. (1994). Ubiquitin-dependent c-jun degradation in vivo is mediated by the δ domain. Cell 78, 787-798.
60. Vogt, P. K. (2001). Jun, the oncoprotein. Oncogene 20, 2365-2377.
61. Wang, P., Anton, M., Graham, F. L., and Bacchetti, S. (1995). High frequency recombination between loxP sites in human chromosomes mediated by an adenovirus vector expressing Cre recombinase. Somat. Cell Mol. Genet. 21, 429-441.
62. Wang, Y., Falasca, M., Schlessinger, J., Malstrom, S., Tsichlis, P., Settleman, J., Hu, W., Lim, B., and Prywes, R. (1998). Activation of the c-fos serum response element by phosphatidyl inositol 3-kinase and rho pathways in HeLa cells. Cell Growth Differ. 9, 513-522.
63. Watanabe, G., Lee, R. J., Albanese, C., Rainey, W. E., Batlle, D., and Pestell, R. G. (1996). Angiotensin II (AII) activation of cyclin D1-dependent kinase activity. J. Biol. Chem. 271, 22570-22577.
64. Weiss, C., Schneider, S., Wagner, E. F., Zhang, X., Seto, E., and Bohmann, D. (2003). JNK phosphorylation relieves HDAC3-dependent suppression of the transcriptional activity of c-Jun. EMBO J. 22, 3686-3695.
65. Westermarck, J. et al. (2002). The DEXD/H-box RNA helicase RHII/Gu is a co-factor for c-Jun-activated transcription. EMBO J. 21, 451-460.
66. Whitmarsh, A. J., Shore, P., Sharrocks, A. D., and Davis, R. J. (1995). Integration of MAP kinase signal transduction pathways at the serum response element. Science 269, 403-407.
67. Whitmarsh, A. J., Yang, S. H., Su, M. S., Sharrocks, A. D., and Davis, R. J. (1997). Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol. Cell Biol. 17, 2360-2371.
68. Wisdom, R., Johnson, R. S., and Moore, C. (1999). c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 18, 188-197.
69. Wu, K. et al. (2003). DACH1 inhibits TGF-beta signaling through binding Smad4. J. Biol. Chem. 278, 51673-51684.
70. Zenz, R., Scheuch, H., Martin, P., Frank, C., Eferl, R., Kenner, L., Sibilia, M., and Wagner, E. F. (2003). c-Jun regulates eyelid closure and skin tumor development through EGFR signaling. Dev. Cell 4, 879-889.